Inventor · disambiguated record
Ian C. Schoenhofen
Also filed as: SCHOENHOFEN IAN · SCHOENHOFEN IAN C
8 granted patents·2 pending applications·7 citations·filing 2006–2021
79Inventor score
Files withNAT RES COUNCIL CANADA5SCHOENHOFEN IAN C2BODDY CHRISTOPHER N1COX ANDREW1NATIONAL RES COUNCIL CANADA1
Top patents by PatentIndex Score
10 records- 0176US9512455B2Cell-based production of nonulosonatesNAT RES COUNCIL CANADA·Filed 2014·Granted Dec 6, 2016·2 cites·11 claims
- 0271US9765106B2Neisseria gonorrhoeae therapeutic based on CMP-nonulosonate sugarsNAT RES COUNCIL CANADA·Filed 2015·Granted Sep 19, 2017·1 cites·9 claims
- 0367US8841099B2Cell-based production of nonulosonatesBODDY CHRISTOPHER N·Filed 2011·Granted Sep 23, 2014·1 cites·11 claims
- 0466US8952183B2Inhibitors of sialidase or sialidase-like enzymesSCHOENHOFEN IAN C·Filed 2010·Granted Feb 10, 2015·2 cites·17 claims
- 0565US9157105B2Biosynthesis of CMP-legionaminic acid from fructose-6-P, and respective pathway intermediates, using novel GDP-linked precursorsSCHOENHOFEN IAN C·Filed 2009·Granted Oct 13, 2015·1 cites·23 claims
- 0660US10301659B2Cell-based production of nonulosonatesNAT RES COUNCIL CANADA·Filed 2016·Granted May 28, 2019·0 cites·19 claims
- 0760US2021401863A1Treatment and prevention of neisseria gonorrhoeae infection using cmp-activated nonulosonate analog compoundsNAT RES COUNCIL CANADA·Filed 2021·Application pending·0 cites
- 0850US10865222B2Neisseria gonorrhoeae therapeutic based on CMP-nonulosonate sugarsNAT RES COUNCIL CANADA·Filed 2017·Granted Dec 15, 2020·0 cites·18 claims
- 0944US2018235989A1Treatment and prevention of neisseria gonorrhoeae infection using cmp-activated nonulosonate analog compoundsNATIONAL RES COUNCIL CANADA·Filed 2016·Application pending·0 cites
- 1036US8975043B2Enzymatic degradation of lipid A fatty acids of bacterial LPSCOX ANDREW·Filed 2006·Granted Mar 10, 2015·0 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →